Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 128 Lung Neoplasms 49 Breast Neoplasms 24 Head and Neck Neoplasms 21 Adenocarcinoma of Lung 18 Brain Neoplasms 15 Neoplasms 14 Adenocarcinoma, Bronchiolo-Alveolar 11 Squamous Cell Carcinoma of Head and Neck 10 Glioblastoma 9 Esophageal Neoplasms 9 Colorectal Neoplasms 9 Rectal Neoplasms 7 Prostatic Neoplasms 7 Neoplasm Metastasis 7 NSCLC 7 Gliosarcoma 7 Colonic Neoplasms 7 Adenocarcinoma Of Esophagus 7 Ovarian Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Adenocarcinoma 5 Urinary Bladder Neoplasms 4 Central Nervous System Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Skin Neoplasms 3 Respiratory Tract Diseases 3 Kidney Neoplasms 3

Interventions

Cyclophosphamide 151 Dexamethasone 140 Rituximab 83 fludarabine 78 Cytarabine 69 Lenalidomide 68 Bortezomib 63 fludarabine phosphate 62 Gemcitabine 62 venetoclax 54 Etoposide 53 pembrolizumab 52 pomalidomide 48 Paclitaxel 48 Cisplatin 47 Carboplatin 47 Peripheral Blood Stem Cell Transplantation 46 Filgrastim 40 Radiotherapy 39 Calcium Dobesilate 36 Busulfan 36 Methotrexate 34 Melphalan 34 Bevacizumab 33 carfilzomib 32 Cyclosporine 32 Azacitidine 32 Mycophenolic Acid 29 Vincristine 28 Temozolomide 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Recurrence × Gefitinib × Clear all

NCT00824746 2013-02-26

ReGaiN

Chonnam National University Hospital

Phase 2 Completed

23 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡